These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B, Bode U, von Schweinitz D. Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356 [Abstract] [Full Text] [Related]
11. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G. J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943 [Abstract] [Full Text] [Related]
12. Impact of postoperative complications on overall survival of patients with hepatoblastoma. Becker K, Furch C, Schmid I, von Schweinitz D, Häberle B. Pediatr Blood Cancer; 2015 Jan 20; 62(1):24-8. PubMed ID: 25251521 [Abstract] [Full Text] [Related]
13. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group. Dall'Igna P, Brugieres L, Christin AS, Maibach R, Casanova M, Alaggio R, de Goyet JV, Zsiros J, Morland B, Czauderna P, Childs M, Aronson DC, Branchereau S, Brock P, Perilongo G. Pediatr Blood Cancer; 2018 Jan 20; 65(1):. PubMed ID: 28921839 [Abstract] [Full Text] [Related]
14. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy. Héry G, Franchi-Abella S, Habes D, Brugières L, Martelli H, Fabre M, Pariente D, Gauthier F, Jacquemin E, Branchereau S. Pediatr Blood Cancer; 2011 Dec 15; 57(7):1270-5. PubMed ID: 21910210 [Abstract] [Full Text] [Related]